Gemcitabine Hydrochloride News : GoldBamboo.com http://goldbamboo.com/ Gemcitabine Hydrochloride News from GoldBamboo.com en-us © 2005, Gold Bamboo LLC, All Rights Reserved FDA Approves Astellas' Vaprisol(R) For The Treatment Of Hypervolemic Hyponatremia http://goldbamboo.com/news-a223800.html Astellas Pharma US, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Vaprisol(R) (conivaptan hydrochloride injection), an arginine vasopressin (AVP) receptor antagonist, for the intravenous treatment of hypervolemic hyponatremia in hospitalized patients. [click link for full article] Sat, 03 Mar 2007 08:00 EST Threshold Pharmaceuticals Announces That A Phase 3 Clinical Trial Of Glufosfamide For Treatment Of Pancreatic Cancer Did Not Meet Its Primary Endpoint http://goldbamboo.com/news-a222842.html Threshold Pharmaceuticals, Inc. (Nasdaq: THLD), today announced that a Phase 3 trial of glufosfamide did not show a statistically significant improvement in overall survival compared to best supportive care (BSC) in patients with metastatic pancreatic cancer who had relapsed after gemcitabine chemotherapy. [click link for full article] Tue, 27 Feb 2007 08:00 EST Arena Pharmaceuticals Completes Enrollment With 3,182 Patients In Lorcaserin Phase 3 BLOOM Trial For Obesity http://goldbamboo.com/news-a219259.html Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that it completed patient enrollment in the first of three planned Phase 3 pivotal trials evaluating the efficacy and safety of its lead drug candidate, lorcaserin hydrochloride, for the treatment of obesity. [click link for full article] Tue, 06 Feb 2007 08:00 EST Tarceva : European Approval For Pancreatic Cancer Treatment http://goldbamboo.com/news-a219026.html Roche's innovative cancer drug Tarceva (erlotinib), has been approved today by the European Commission for the treatment of patients with metastatic pancreatic cancer, in combination with a standard chemotherapy, gemcitabine. Tarceva is the first treatment in over a decade to have shown a significant survival benefit in treating patients with this devastating disease. [click link for full article] Mon, 05 Feb 2007 08:00 EST Par Pharmaceutical Receives Approval Of Generic Inderal-LA(R) http://goldbamboo.com/news-a218050.html Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced it has received final approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application for propranolol hydrochloride (HCl) extended release (ER) capsules in 60-, 80-, 120- and 160 mg dosage strengths. [click link for full article] Tue, 30 Jan 2007 08:00 EST